Headlines
Bloomberg MarketsElliott Is Said to Take Stake in Air LiquideBloomberg MarketsNIB CEO Says Defense Project Pipeline Has Increased RapidlyFinancial TimesGlobal bond sell-off deepens amid inflation fearsBloomberg MarketsBond Slide Grips Emerging Markets as Fed Risk Drags SentimentBloomberg MarketsTaiwan Fines Cathay SITE, Restricts Offshore Trust OfferingsBloomberg MarketsSouth African Factory Mood Sours as Production Momentum SlowsFinancial TimesShein shares slide as much as 10% in Hong Kong debutFinancial TimesEurozone inflation rises to 3.3% in AugustBloomberg MarketsShein’s Debut Shows the Cost of IPO Missing Its Growth PeakBloomberg MarketsNigeria’s Fuel Subsidy Returns as Key Election BattlegroundBloomberg MarketsRise in Real Yields Has Further to Run, Nuveen SaysFinancial TimesPartners Group replaces chief executive as pressure grows on flagship fundBloomberg MarketsH.I.G. Is Said to Consider Sale of $1 Billion Drugmaker Rising PharmaBloomberg MarketsAdam Posen Thinks Things Could Get 'Messy' for the FedBloomberg MarketsChinese Banks Extend Record-Breaking Rally on Earnings, DividendBloomberg MarketsElliott Is Said to Take Stake in Air LiquideBloomberg MarketsNIB CEO Says Defense Project Pipeline Has Increased RapidlyFinancial TimesGlobal bond sell-off deepens amid inflation fearsBloomberg MarketsBond Slide Grips Emerging Markets as Fed Risk Drags SentimentBloomberg MarketsTaiwan Fines Cathay SITE, Restricts Offshore Trust OfferingsBloomberg MarketsSouth African Factory Mood Sours as Production Momentum SlowsFinancial TimesShein shares slide as much as 10% in Hong Kong debutFinancial TimesEurozone inflation rises to 3.3% in AugustBloomberg MarketsShein’s Debut Shows the Cost of IPO Missing Its Growth PeakBloomberg MarketsNigeria’s Fuel Subsidy Returns as Key Election BattlegroundBloomberg MarketsRise in Real Yields Has Further to Run, Nuveen SaysFinancial TimesPartners Group replaces chief executive as pressure grows on flagship fundBloomberg MarketsH.I.G. Is Said to Consider Sale of $1 Billion Drugmaker Rising PharmaBloomberg MarketsAdam Posen Thinks Things Could Get 'Messy' for the FedBloomberg MarketsChinese Banks Extend Record-Breaking Rally on Earnings, Dividend
Home/Bloomberg Markets
Back
MARKETS:
SPY+0.26%
DIA+0.23%
QQQ-0.14%
IWM+0.29%
GLD-0.40%
USO+1.64%
Bloomberg Marketsglobal

H.I.G. Is Said to Consider Sale of $1 Billion Drugmaker Rising Pharma

Bloomberg Markets
Tuesday, September 1, 2026 at 8:29 AM
~4 min read

Original Report

H.I.G. Capital is exploring options for its controlling stake in US-based Rising Pharmaceuticals, including a possible sale, according to people familiar with the matter.

Glass House Analysis

This story reflects the interconnected nature of modern economic systems, where developments in one sector inevitably affect others. Understanding these connections is essential for grasping how policy decisions and market movements translate into real-world outcomes for families, workers, and communities. The economy is not an abstract system of numbers—it's the sum total of decisions about who works, who prospers, and who struggles.

The implications extend beyond the immediate news cycle. Every economic development creates ripples that affect employment, prices, and opportunities in ways that may not be immediately visible but are deeply felt. By tracking these connections, we can better understand how the economy truly works—not as an abstract machine, but as a human system shaped by and shaping the lives of millions.

Enjoyed this analysis?

Get the Glass House Briefing every morning—market news that actually makes sense, delivered free to your inbox.

No spam. Unsubscribe anytime.

More Stories

Economic Context

S&P 500
+0.26%
Dow Jones
+0.23%
NASDAQ 100
-0.14%
Russell 2000
+0.29%